Amniotic fluid interleukin-18 at mid-trimester genetic amniocentesis: relationship to intraamniotic microbial

G Daskalakis1, N Thomakos, A Papapanagiotou

  • 1First Department of Obstetrics and Gynaecology, Alexandra Maternity Hospital, and Department of Biological Chemistry, Athens University, Athens, Greece. gdaskalakis@yahoo.com

Abstract

Insights

Elevated amniotic fluid interleukin-18 (AF IL-18) levels in the mid-trimester can help identify women at risk for intraamniotic infection and spontaneous preterm delivery (PTD). This biomarker aids in predicting PTD.

Area of Science:

  • Reproductive Medicine
  • Obstetrics
  • Biomarkers

Background:

  • Microbial invasion of the amniotic cavity is a significant cause of preterm delivery (PTD).
  • Accurate diagnosis and prediction of PTD remain clinical challenges.

Purpose of the Study:

  • To evaluate the diagnostic and predictive value of amniotic fluid interleukin-18 (AF IL-18) for intraamniotic infection.
  • To assess the utility of AF IL-18 in predicting spontaneous preterm delivery (PTD).

Main Methods:

  • Prospective analysis of amniotic fluid (AF) collected via genetic amniocentesis.
  • AF IL-18 levels were measured alongside aerobic/anaerobic bacterial and Ureaplasma urealyticum cultures.
  • Women delivering preterm (<37 weeks) were compared to matched term delivery controls.

Main Results:

  • Significantly higher AF IL-18 concentrations were observed in the preterm delivery group compared to controls (P<0.001).
  • Elevated AF IL-18 levels correlated with positive amniotic fluid cultures, indicating intraamniotic infection (P<0.001).

Conclusions:

  • Mid-trimester elevation of AF IL-18 is a valuable indicator for women at risk of intraamniotic infection.
  • Increased AF IL-18 concentrations can identify women at risk for spontaneous preterm delivery.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...